DEXIS Announces Clearance of Artificial Intelligence Findings on 2D Radiographs


The company received FDA clearance for its DTX Studio Clinic, which can identify 6 types of pathological dental findings on periapical and bitewing intraoral images.

DEXIS 2D AI Findings | ©Envista

DEXIS has announced its DTX Studio™ Clinic has received US Food and Drug Administration (FDA) clearance for artificial intelligence (AI) findings on 2D intraoral x-ray images. DTX Studio Clinic now offers 6 types of pathological dental findings on periapical and bitewing intraoral images and is fully integrated into a practice’s imaging software, according to a press release from DEXIS.

DTX Studio Clinic is designed to screen dental radiographs and annotate suspected areas of interest, allowing clinicians to make informed decisions about diagnosis and treatment. These can include 6 types of pathological dental findings: caries, discrepancy at margin, root canal defects, periapical radiolucency, bone loss, and calculus. DTX Studio Clinic allows clinicians to present patients with a more comprehensive view of their diagnosis and treatment plan, which is said to build patient understanding and increase practice efficiency.

DEXIS DTX Studio Clinic AI 2D dental findings | ©Envista

DEXIS' new DTX Studio Clinic uses AI to highlight 6 types of pathological findings on 2D radiographs, including caries.

“DEXIS is empowering practices to embrace digital dentistry for improved efficiencies and predictable patient outcomes,” Amir Aghdaei, CEO of Envista, DEXIS’ parent company, said, according to the press release. “With our newest release of DTX Studio Clinic, featuring enhanced built-in AI features like the pathological dental findings, practices now have an enhanced solution for their digital workflow — from diagnosis to treatment planning to delivery of care.”

Clinicians interested to try DTX Studio Clinic AI 2D dental findings can sign up on the DEXIS website.

Recent Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Dental Products Report Spring Selection Bracket Reveal Video
Mastermind Episode 33 – Charting the Course for the Future of Dentistry
CDS 2024 Midwinter Meeting – Interview with Debbie Zafiropoulos, who discusses a trio of new infection control products from Armis Biopharma.
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
© 2024 MJH Life Sciences

All rights reserved.